Bruton’s Tyrosine Kinase (BTK) Inhibition Promotes Myelin Repair in Two Different Models of Demyelination (3983)
Marie‐Stéphane Aigrot(Sorbonne Université), Bernard Zalc(Institut du Cerveau), Bruno Stankoff(Pitié-Salpêtrière Hospital), E. Martin(Institut de Cancérologie de l'Ouest), Roland Grenningloh(Merck KGaA, Darmstadt (Germany)), Ursula Boschert(Merck Serono S.A. (Switzerland)), Catherine Lubetzki(Centre National de la Recherche Scientifique)
Cited by 0
Related Papers
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
|Multiple Sclerosis Journal|2018|706
Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines
|Brain|2019|554
Myelin-oligodendrocyte glycoprotein antibody-associated disease
|The Lancet Neurology|2021|518